2013
DOI: 10.1684/ejd.2013.2160
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous polyarteritis nodosa localized to the arm receiving an infusion of abatacept

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Both infections and subsequent tissue trauma probably damaged lymphatic vessels . Similarly, a case of localized CPAN to the left arm was found after a patient had repeated infusions of abatacept to the area, possibly causing tissue and vessel trauma as well as disrupting the lymphatics and/or altering an immune response because of large local dose of abatacept …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Both infections and subsequent tissue trauma probably damaged lymphatic vessels . Similarly, a case of localized CPAN to the left arm was found after a patient had repeated infusions of abatacept to the area, possibly causing tissue and vessel trauma as well as disrupting the lymphatics and/or altering an immune response because of large local dose of abatacept …”
Section: Discussionmentioning
confidence: 99%
“…10 Similarly, a case of localized CPAN to the left arm was found after a patient had repeated infusions of abatacept to the area, possibly causing tissue and vessel trauma as well as disrupting the lymphatics and/or altering an immune response because of large local dose of abatacept. 13 All of the aforementioned cases emphasize the importance of lymph flow and how disruptions in it, may predispose to the development of CPAN. Immune-complex disease is initiated when antigen and antibody are in a one to one ratio, or slight excess of antigen.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Reported cutaneous reactions after treatment with abatacept, including rheumatoid vasculitis, cutaneous polyarteritis nodosa localized to the infusion site, pyoderma gangrenosum, erythema elevatum diutinum, psoriasis, and Sweet syndrome, have mostly been described in patients with rheumatoid arthritis. 2 , 3 , 4 , 5 …”
Section: Introductionmentioning
confidence: 99%